San Francisco, California, United States
Francisco LePort, Martin Borch
2018
Private company
Seed
1.5
The Longevity Fund, Formic Ventures, Prime Mover Labs, Jeff Dean
gene therapy
Developer of a gene therapy discovery platform intended to improve therapeutic research for complex diseases related to aging. The company's platform researches and develops therapies which can prevent pre-mature aging in humans, enabling patients to reduce aging and improve their skin conditions.